Day One Biopharmaceuticals, Inc (NASDAQ:DAWN) Receives Average Recommendation of Moderate Buy from Analysts themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Free Report) saw an uptick in trading volume on Wednesday after Needham & Company LLC raised their price target on the stock from $30.00 to $33.00. Needham & Company LLC currently has a buy rating on the stock. 1,343,090 shares traded hands during mid-day trading, an increase of […]
New York State Common Retirement Fund lessened its stake in MetLife, Inc. (NYSE:MET – Free Report) by 12.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 927,409 shares of the financial services provider’s stock after selling 135,640 shares during the period. New York State […]
Day One Biopharmaceuticals (NASDAQ:DAWN – Get Free Report)‘s stock had its “outperform” rating reiterated by stock analysts at Wedbush in a report issued on Wednesday, RTT News reports. They currently have a $33.00 price objective on the stock. Wedbush’s price target indicates a potential upside of 114.98% from the stock’s current price. A number of […]
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Free Report) insider Samuel C. Blackman sold 10,000 shares of Day One Biopharmaceuticals stock in a transaction dated Thursday, April 18th. The stock was sold at an average price of $16.02, for a total value of $160,200.00. Following the sale, the insider now directly owns 1,174,662 shares in […]